Clinical Trials · NCT02668588
Extended-release of Octreotide (LF-PB) for the Treatment of Seroma
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Chemi S.p.A.
- Enrollment
- 48
- Start date
- Oct 2015
- Locations
- 7 sites, Italy
- Primary endpoint
- Incidence of seromas requiring an aspiration